Intriguingly, here we found that circulating levels of hFABP and acylcarnitines (C12:0, C14:0, C14:1, C14:2, C16:1) were jointly increased in MACE and HF patients, suggesting that the circulating levels may have a dual role in both ischemic and HF events. The gene discussed is FABP3; the disease is hydrops fetalis.